Literature DB >> 18087722

The history of cytomegalovirus and its diseases.

Monto Ho1.   

Abstract

Intranuclear inclusions typical of cytomegalovirus infections were first noticed in 1881 by German scientists who thought they represented protozoa. After viruses were grown in cell cultures, Weller, Smith and Rowe independently isolated and grew CMV from man and mice in 1956-1957. Antibodies in 30-100% of normal adults indicate not only a past infection, but the presence of a present latent infection. The presence of CMV DNA in tissues and most organs surveyed indicates the ubiquity of latent infection. CMV disease requires the virus and some deficiency of immunity such as occurs in the immature fetus, in AIDS, and in transplant patients on immunosuppressive drugs. Antiviral agents can inhibit CMV replication but they cannot prevent or cure latent infections. A pharmacological approach using the many leads in understanding latency is needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18087722     DOI: 10.1007/s00430-007-0066-x

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  56 in total

1.  Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 2.  Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.

Authors:  Nina Singh
Journal:  Clin Infect Dis       Date:  2005-02-04       Impact factor: 9.079

3.  Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease.

Authors:  G J Demmler
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

4.  Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids.

Authors:  E C Reed; P S Dandliker; J D Meyers
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

5.  The transplanted kidney as a source of cytomegalovirus infection.

Authors:  M Ho; S Suwansirikul; J N Dowling; L A Youngblood; J A Armstrong
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

6.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

7.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

8.  Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus.

Authors:  T A Price; R A Digioia; G L Simon
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

9.  Cytomegalovirus infections in homosexual men. An epidemiological study.

Authors:  L Mintz; W L Drew; R C Miner; E H Braff
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

10.  Cytomegalovirus infection in children undergoing open-heart surgery.

Authors:  J A Armstrong; G C Tarr; L A Youngblood; J N Dowling; A R Saslow; J P Lucas; M Ho
Journal:  Yale J Biol Med       Date:  1976-03
View more
  67 in total

1.  Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR.

Authors:  Reinhard B Raggam; Michael Bozic; Helmut J F Salzer; Sandra Hammerschmidt; Cordula Homberg; Katharina Ruzicka; Harald H Kessler
Journal:  Med Microbiol Immunol       Date:  2010-06-18       Impact factor: 3.402

Review 2.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

3.  Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.

Authors:  John E Tavis; Hong Wang; Ann E Tollefson; Baoling Ying; Maria Korom; Xiaohong Cheng; Feng Cao; Katie L Davis; William S M Wold; Lynda A Morrison
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

4.  Margaret Gladys Smith, mother of cytomegalovirus: 60th anniversary of cytomegalovirus isolation.

Authors:  Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2015-04-12       Impact factor: 3.402

Review 5.  Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.

Authors:  Astrid Krmpotić; Jürgen Podlech; Matthias J Reddehase; William J Britt; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2019-03-28       Impact factor: 3.402

Review 6.  A spatial view of the CD8+ T-cell response: the case of HCV.

Authors:  Vito Racanelli; Patrizia Leone; Arash Grakoui
Journal:  Rev Med Virol       Date:  2011-07-05       Impact factor: 6.989

7.  A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers.

Authors:  Kiran Dole; Florencia Pereyra Segal; Adam Feire; Baldur Magnusson; Juan C Rondon; Janardhana Vemula; Jing Yu; Yinuo Pang; Peter Pertel
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms.

Authors:  Marc Becker; Niels A W Lemmermann; Stefan Ebert; Pamela Baars; Angelique Renzaho; Jürgen Podlech; Michael Stassen; Matthias J Reddehase
Journal:  Cell Mol Immunol       Date:  2014-08-25       Impact factor: 11.530

9.  Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.

Authors:  Peter D Burbelo; Alexandra T Issa; Kathryn H Ching; Maurice Exner; W Lawrence Drew; Harvey J Alter; Michael J Iadarola
Journal:  Virol J       Date:  2009-05-01       Impact factor: 4.099

Review 10.  Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.

Authors:  Martin Stürmer; Hans Wilhelm Doerr; Lutz Gürtler
Journal:  Med Microbiol Immunol       Date:  2009-06-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.